Skip to main content

Table 3 Serum concentration of markers of inflammation and glucose metabolism

From: Fish protein supplementation in older nursing home residents: a randomised, double-blind, pilot study

  Baseline Endpoint Mean difference in change between groupsa
Mean (SD) Mean (SD) Mean (95% CI)
MCP-1, pg/ml
 Intervention group 178 (70) 159 (63) − 80 (− 146, − 13)*
 Control group 364 (324) 425 (401)  
CRP, mg/l
 Intervention group 3.77 (7.68) 6.29 (8.91) 0.77 (− 6.83, 8.37)*
 Control group 8.71 (11.50) 10.46 (17.14)  
Glucose, mmol/l
 Intervention group 5.82 (1.00) 5.77 (1.14) − 0.02 (− 0.41, 0.38)
 Control group 5.59 (0.62) 5.56 (0.62)  
Insulin, ng/ml
 Intervention group 0.36 (0.13) 0.34 (0.12) − 0.09 (− 0.23,0.04)
 Control group 0.51 (0.42) 0.58 (0.61)  
Fructosamine, μmol/l
 Intervention group 280 (40) 280 (36) 2.86 (−13.74, 19.46)
 Control group 259 (26) 256 (31)  
  1. Data is presented as mean and standard deviation with n = 12 in the intervention group and n = 9 in the control group. For serum insulin concentrations, one participant in the intervention group used insulin and was therefore excluded; thus, results are presented for n = 11 in the intervention group and n = 9 in the control group. The groups were similar at baseline (independent samples t test). MCP-1, CRP and insulin were log-transformed prior to testing; within-group changes were tested using paired samples t test, and no significant changes within groups were observed. Within group changes were compared between groups using independent samples t test. p value < 0.05 was considered significant. MCP-1 monocyte chemoattractant protein-1; CRP C-reactive protein; CI confidence interval
  2. aMean difference in change between groups shows change in control group minus change in intervention group
  3. *Reflects significant differences in mean change between intervention group and control group